S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chen, Xue ^a   Liu, Xinjuan ^b   Lang, Haibo ^a   Zhang, Shiqi ^a   Luo, Yanlin ^c   Zhang, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM BINDING PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; S100 CALCIUM BINDING PROTEIN A6; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CELL CYCLE PROTEIN; PROTEIN S 100; S100A6 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN EXPRESSION; ADENOCARCINOMA; CELL MOTION; GENETICS; METABOLISM; PANCREAS TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; BETA CATENIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; PANCREATIC NEOPLASMS; S100 PROTEINS;

EID: 84925702490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121319     Document Type: Article

References (35)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29. doi: 10.3322/caac.21208 PMID: 24399786
2. Long J, Luo GP, Xiao ZW, Liu ZQ, Guo M, Liu L, et al. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014; 346: 273-277. doi: 10.1016/j.canlet.2014.01.004 PMID: 24462819
3. Cao H, Le D, Yang LX. Current status in chemotherapy for advanced pancreatic adenocarcinoma. Anticancer Res. 2013; 33: 1785-1791. PMID: 23645722
4. Ji YF, Huang H, Jiang F, Ni RZ, Xiao MB. S100 family signaling network and related proteins in pancreatic cancer (Review). Int J Mol Med. 2014; 33: 769-776. doi: 10.3892/ijmm.2014.1633 PMID: 24481067
5. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003; 63: 2649-2657. PMID: 12750293
6. Zihao G, Jie Z, Yan L, Jing Z, Jing C, Xue L, et al. Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer. J Clin Gastroenterol. 2013; 47: 69-75. doi: 10.1097/MCG.0b013e3182601752 PMID: 22914344
7. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res. 2005; 11: 7785-7793. PMID: 16278400
8. Jurewicz E, Bednarczyk J, Bot A, Lukasiuk K, Filipek A. Status epilepticus induces long lasting increase in S100A6 expression in astrocytes. Neurochem Res. 2013; 38: 1941-1948. doi: 10.1007/s11064-013-1100-6 PMID: 23817846
9. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012; 149: 1192-1205. doi: 10.1016/j.cell.2012.05.012 PMID: 22682243
10. Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014; 13: 513-532. doi: 10.1038/nrd4233 PMID: 24981364
11. Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, et al. The way Wnt works: components and mechanism. Growth Factors. 2013; 31: 1-31. doi: 10.3109/08977194.2012.752737 PMID: 23256519
12. Ueno K, Hirata H, Hinoda Y, Dahiya R. Frizzled homolog proteins, microRNAs and Wnt signaling in cancer. Int J Cancer. 2013; 132: 1731-1740. doi: 10.1002/ijc.27746 PMID: 22833265
13. Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012; 487: 510-513. doi: 10.1038/nature11217 PMID: 22763454
14. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, et al. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia. 2010; 15: 261-273. doi: 10.1007/s10911-010-9174-0 PMID: 20449641
15. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010; 15: 117-134. doi: 10.1007/s10911-010-9178-9 PMID: 20490631
16. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9: 265-273. doi: 10.1038/nrc2620 PMID: 19262571
17. Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ. Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression. J Surg Res. 2012; 173: 105-112. doi: 10.1016/j.jss.2011.09.020 PMID: 22099597
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3: 1101-1108. PMID: 18546601
19. Lesniak W, Slomnicki LP, Filipek A. S100A6-new facts and features. Biochem Biophys Res Commun. 2009; 390: 1087-1092. doi: 10.1016/j.bbrc.2009.10.150 PMID: 19891957
20. Li Z, Tang M, Ling B, Liu S, Zheng Y, Nie C, et al. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. J Mol Med (Berl). 2014; 92: 291-303. doi: 10.1007/s00109-013-1104-3 PMID: 24281831
21. Zhang J, Zhang K, Jiang X, Zhang J. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer. Dig Dis Sci. 2014; 59: 2136-2144. doi: 10.1007/s10620-014-3137-z PMID: 24705642
22. Vimalachandran D, Greenhalf W, Thompson C, Luttges J, Prime W, Campbell F, et al. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res. 2005; 65: 3218-3225. PMID: 15833853
23. Ohuchida K, Mizumoto K, Yu J, Yamaguchi H, Konomi H, Konomi H, et al. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples. Cancer Epidemiol Biomarkers Prev. 2007; 16: 649-654. PMID: 17416753
24. Rosenbluh J, Wang X, Hahn WC. Genomic insights into WNT/beta-catenin signaling. Trends Pharmacol Sci. 2014; 35: 103-109. doi: 10.1016/j.tips.2013.11.007 PMID: 24365576
25. Nowotny M, Bhattacharya S, Filipek A, Krezel AM, Chazin W, Kuznicki J. Characterization of the interaction of calcyclin (S100A6) and calcyclin-binding protein. J Biol Chem. 2000; 275: 31178-31182. PMID: 10884380
26. Lee YT, Dimitrova YN, Schneider G, Ridenour WB, Bhattacharya S, Soss SE, et al. Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition. Biochemistry. 2008; 47: 10921-10932. doi: 10.1021/bi801233z PMID: 18803400
27. Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell. 2001; 7: 915-926. PMID: 11389839
28. Filipek A. S100A6 and CacyBP/SIP-two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin. Chemotherapy. 2006; 52: 32-34. PMID: 16340196
29. Zhai H, Shi Y, Jin H, Li Y, Lu Y, Chen X, et al. Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J Histochem Cytochem. 2008; 56: 765-772. doi: 10.1369/jhc.2008.950519 PMID: 18443365
30. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013; 13: 97-110. doi: 10.1038/nrc3447 PMID: 23344542
31. Bo H, Zhang S, Gao L, Chen Y, Zhang J, Chang X, et al. Upregulation of Wnt5a promotes epithelial-tomesenchymal transition and metastasis of pancreatic cancer cells. BMC Cancer. 2013; 13: 496. doi: 10.1186/1471-2407-13-496 PMID: 24156409
32. Xu W, Wang Z, Zhang W, Qian K, Li H, Kong D, et al. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/beta-catenin signaling pathway. Cancer Lett. 2015. In Press.
33. Gao ZH, Lu C, Wang MX, Han Y, Guo LJ. Differential beta-catenin expression levels are associated with morphological features and prognosis of colorectal cancer. Oncol Lett. 2014; 8: 2069-2076. PMID: 25295092
34. Wang Y, Bu F, Royer C, Serres S, Larkin JR, Soto MS, et al. ASPP2 controls epithelial plasticity and inhibits metastasis through beta-catenin-dependent regulation of ZEB1. Nat Cell Biol. 2014; 16: 1092-1104. doi: 10.1038/ncb3050 PMID: 25344754
35. Xu X, Su B, Xie C, Wei S, Zhou Y, Liu H, et al. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells. PLoS One. 2014; 9: e96441. doi: 10.1371/journal.pone.0096441 PMID: 25072505